Woodline Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-712,910
Closed -$36.4M 1067
2024
Q4
$36.4M Buy
+712,910
New +$35M 0.25% 126
2024
Q3
Sell
-92,484
Closed -$4.45M 729
2024
Q2
$4.45M Buy
+92,484
New +$4.1M 0.04% 353
2022
Q1
Sell
-30,143
Closed -$2.75M 840
2021
Q4
$2.75M Sell
30,143
-60,295
-67% -$5.17M 0.04% 376
2021
Q3
$7.33M Buy
+90,438
New +$7.6M 0.12% 207
2021
Q1
Sell
-21,635
Closed -$1.89M 484
2020
Q4
$1.89M Buy
+21,635
New +$1.53M 0.05% 197
2020
Q3
Sell
-13,409
Closed -$650K 220
2020
Q2
$650K Buy
+13,409
New +$640K 0.03% 143

Other funds holding NARI

Woodline Partners's NARI Position: Q1 2025 in Review

Woodline Partners sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 712,910 shares — an estimated $36.4M sold.

Woodline Partners first reported a position in NARI in Q2 2020 and held it in 6 quarters. The position peaked at $36.4M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Woodline Partners reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Woodline Partners sold 712,910 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $36.4M.
  • Woodline Partners first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • Woodline Partners's Inari Medical, Inc. Common Stock position peaked at $36.4M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Woodline Partners's 13F filing for Q1 2025, filed 15 May 2025.